New insights on diabetes treatment, management, and technology emerged from the European Association for the Study of Diabetes (EASD) 2026 conference in Milan, Italy. Here’s what matters most for ...
Compelling research has shown that resistance exercises like push-ups, squats, and lunges are beneficial for blood sugar management. Here's how to get started. Aerobic exercise has always held a ...
Unlike FDA-approved GLP-1 medications like Ozempic and Wegovy, dietary supplements like Lemme GLP-1 Daily do not require FDA approval or any data to support their marketing claims. Limited research ...
Consuming foods that are high in protein and fiber tends to impact blood sugar less than those made with simple or refined carbohydrates and added sugar. Foods that don’t spike blood sugar as much ...
Some simple planning and small adjustments can help your CGM stay connected. Positioning, application and adhesion tips can assist in keeping sensors in place and avoiding skin irritation. Online ...
Nausea and stomach problems are well-known reactions to GLP-1s, but you may be less familiar with other potential side effects of these powerful medications. With more and more people using GLP-1 ...
The FDA has approved finerenone (Kerendia) for people with type 1 diabetes and chronic kidney disease. It’s the first new drug for type 1-associated kidney disease in 30 years. Treatments for chronic ...
Janelle Tobias Sanderson shares her personal experiences and strategies for navigating college with type 1 diabetes. College is an exciting time when you grow into your identity and get to decide what ...
Joanne Milo, author of “The Savvy Diabetic” and founder of Loop and Learn, talks about adapting to life with type 1 – and building resilience – in your late 40s and early 50s. When Joanne Milo was ...
Here are some of the top technology highlights covered at the American Diabetes Association's 2026 scientific conference in New Orleans. Broadening access to diabetes technology and developing new ...
Medtronic’s MiniMed 780G automated insulin delivery system is FDA-cleared for use in people with type 1 diabetes ages 7 and above and adults (ages 18 and older) with type 2. The automated insulin ...
T1D Exchange Registry data reveals only 17% of youth and 21% of adults are meeting A1C goals, even though more are on pumps and CGM Recently, the T1D Exchange Clinic Network released the “State of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results